Balaxi Pharmaceuticals Limited (BALAXI)

Price453.45 -0.75 (-0.17%)52 Week High670.00
ISININE618N0101452 Week Low434.85
IndustryMedical DistributorsVolume1,182
SectorDistribution ServicesP/E Ratio TTM9.00
Market Cap4.6 B1 Year Beta0.10
Technical Rating of
  • BALAXI PHARMACEUTICALS LIMITED (BALAXI) is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat, India. It was incorporated in 1994.
  • The company’s initial focus was on the manufacturing of generic formulations. It has since expanded its operations to include a wide range of products, including branded formulations, over-the-counter products, and neutraceuticals.
  • BALAXI Pharmaceuticals is one of the leading pharmaceutical companies in India. The company has a pan-India presence and exports its products to over 30 countries.
  • BALAXI Pharmaceuticals is a publicly traded company, listed on the Bombay Stock Exchange and the National Stock Exchange of India. The company has a market capitalization of over ₹500 crore (US$62.5 million).
  • BALAXI Pharmaceuticals is well-positioned for continued growth in the future. The company is targeting to expand its geographic reach and increase its market share.

Here are some of the key points about BALAXI PHARMACEUTICALS LIMITED:

  • Founded in 1994
  • Headquartered in Ahmedabad, Gujarat, India
  • One of the leading pharmaceutical companies in India
  • Pan-India presence and exports to over 30 countries
  • Publicly traded company
  • Market capitalization of over ₹500 crore (US$62.5 million)
  • Well-positioned for continued growth in the future
  • The company has a strong focus on innovation. It was one of the first Indian pharmaceutical companies to introduce a continuous manufacturing process.
  • BALAXI Pharmaceuticals is also a major supplier of pharmaceutical products to the Indian government.
          

Technical Analysis of Balaxi Pharmaceuticals Limited (BALAXI)

Doji
Doji is formed on Balaxi Pharmaceuticals Limited (BALAXI) in 1 Day Timeframe. Doji are used in technical analysis to help identify securities price patterns. A doji names a trading session in which a security has an open and close that are virtually equal, which resembles a candlestick on a chart. The word doji comes from the Japanese phrase meaning 'the same thing.' A doji candlestick is a neutral indicator that provides little information. They are rare, so they are not reliable for spotting things like price reversals. Doji formations come in three major types: gravestone, long-legged, and dragonfly.

Moving Averages

PeriodSimpleExponential
MA 5454.92454.70
MA 10455.83456.28
MA 20459.30460.35
MA 30462.39465.65
MA 50478.66476.70
MA 100508.09497.10
MA 200531.85513.25

Moving Average Rating

Technical Indicators

NameValueNameValue
Aroon Up (14)42.86Aroon Down (14)85.71
MACD Level (12, 26)-6.46MACD Signal (12, 26)-7.24
Relative Strength Index (7)39.44Relative Strength Index (14)40.23
Stochastic %D (14 3 3)38.31Stochastic %K (14 3 3)39.95
Stochastic RSI Fast (3, 3, 14, 14)52.59Stochastic RSI Slow (3, 3, 14, 14)55.81
Bollinger Upper Band (20)471.54Bollinger Lower Band (20)447.06
Keltner Channels Upper Band (20)489.73Keltner Channels Lower Band (20)430.96
Donchian Channels Upper Band (20)484.00Donchian Channels Lower Band (20)434.85
Ichimoku Conversion Line (9, 26, 52, 26)459.43Ichimoku Base Line (9, 26, 52, 26)463.40
Ichimoku Leading Span A (9, 26, 52, 26)478.90Ichimoku Leading Span B (9, 26, 52, 26)498.23
Positive Directional Indicator (14)12.67Negative Directional Indicator (14)25.69
Volume Weighted Average Price452.17Volume Weighted Moving Average 20458.94

Oscillator Rating

Oscillators

Awesome Oscillator-11.26
Ultimate Oscillator (7,14,28)49.35
Money Flow (14)45.04
Chaikin Money Flow (20)-0.31
Commodity Channel Index (20)-105.01
Bull Bear Power-11.64

High / Low

1 Month484.00434.85
3 Month545.00434.85
6 Month665.00434.85
52 Week670.00434.85
All Time1,080.2011.50

Volume

Volume1,182.00
Average 10 D3,070.40
Average 30 D2,775.03
Average 60 D3,889.40
Average 90 D5,650.62

Change/Volatility

Change-0.75 (-0.17%)
Change 1W-0.70 (-0.15%)
Change 1M-5.10 (-1.11%)
Volatility3.44
Volatility W3.35

Performance

Yesterday-27.45
Weekly-0.10
Monthly-5.53
3 Month-12.33
6 Month-16.03
Yearly-16.34
5 Year1,491.05
All Time3,388.08

Misc.

Average Day Range (14)13.50
Average Directional Index (14)20.34
Average True Range (14)15.06
Williams Percent Range (14)-62.16
Rate Of Change (9)-3.64
Hull Moving Average (9)455.14
Momentum (10)-16.00
Parabolic SAR475.33

PIVOT POINTS of Balaxi Pharmaceuticals Limited (BALAXI)

NameS3S2S1Pivot PointsR1R2R3
Classic311.23392.78425.67474.33507.22555.88637.43
Fibonacci392.78423.94443.18474.33505.49524.73555.88
Camarilla436.12443.60451.07474.33466.03473.50480.98
Woodie's349.48395.46431.02477.01512.57558.56594.12
DeMark's - - 409.23466.11490.77 - -

Financial Analysis of Balaxi Pharmaceuticals Limited (BALAXI)

Income Statement

Basic EPS (FY)47.66
Basic EPS (TTM)50.55
EBITDA (Annual YoY Growth)24.53
EBITDA (Quarterly QoQ Growth)-465.26
EBITDA (Quarterly YoY Growth)-357.53
EBITDA (TTM)616.1 M
EBITDA (TTM YoY Growth)23.54
EPS Diluted (Annual YoY Growth)24.96
EPS Diluted (FY)47.66
EPS Diluted (Quarterly QoQ Growth)-604.23
EPS Diluted (Quarterly YoY Growth)-418.56
EPS Diluted (TTM)50.37
EPS Diluted (TTM YoY Growth)16.31
Free Cash Flow Margin (FY)10.08
Gross Profit (Annual YoY Growth)44.41
Gross Profit (FY)882.5 M
Gross Profit (MRQ)240.6 M
Gross Profit (Quarterly QoQ Growth)-17.27
Gross Profit (Quarterly YoY Growth)-24.58
Gross Profit (TTM YoY Growth)94.93
Last Year Revenue (FY)2.8 B
Revenue (Annual YoY Growth)21.75
Revenue per Employee (FY)60.5 M
Revenue (Quarterly QoQ Growth)-20.81
Revenue (Quarterly YoY Growth)-30.29
Revenue (TTM YoY Growth)44.25
Net Income (Annual YoY Growth)24.96
Net Income (FY)476.6 M
Net Income (Quarterly QoQ Growth)-602.41
Net Income (Quarterly YoY Growth)-425.27
Net Income (TTM YoY Growth)16.77
Total Revenue (FY)2.8 B

Valuation

Enterprise Value/EBITDA (TTM)7.54
Number of Employees47.00
Number of Shareholders3,988.00
Shares Float1.6 M
Price to Book (FY)4.01
Price to Earnings Ratio (TTM)9.00
Price to Revenue Ratio (TTM)1.32
Price to Sales (FY)1.59
Total Shares Outstanding10.2 M

Balance Sheet

Total Assets (Annual YoY Growth)77.04
Total Debt (Annual YoY Growth)-0.58
Total Liabilities (FY)633.1 M
Cash & Equivalents (FY)71.9 M
Cash and short term investments (FY)71.9 M

Operating Metrics

Dividends

Dividends per Share (FY)0.50

Margins

Net Margin (FY)16.76
Net Margin (TTM)14.38
Gross Margin (FY)31.04
Gross Margin (TTM)39.34
Operating Margin (FY)19.52
Operating Margin (TTM)17.30
Pretax Margin (TTM)17.30

Leave a Reply

Your email address will not be published. Required fields are marked *

Stock Sectors
Stock Industries